Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on X:
“To Madrid to participate in the largest European cancer conference, proud to lead the largest Arab participation with 9 specialized scientific research papers in the field of cancer, tumors, and artificial intelligence Nexomic, using ctDNA technology in the diagnosis and follow-up of cancer recovery, and presenting 10 cases of complete cancer recovery in stage four.
I am honored to lead the team from Burjeel Oncology Institute and Nexomic for Artificial Intelligence and Cancer, and to present our research and discuss it with the world’s leading scientists in this field. Proud of the tremendous progress in the cancer and oncology sector in the United Arab Emirates, with the support and patronage of our wise leadership. We ask God for success and guidance in what serves all of humanity.”
You can also read: OncoDaily at ESMO 2026: Where Science Meets Community
